8 research outputs found

    Cost-Benefit Analysis of Egypt’s Free Economic Zones: A Way Forward for Libya

    Get PDF
    Libya has an economy over dependent on hydrocarbon and the petroleum industry. In a bid to diversify, the Libyan government is looking at Free Economic Zones (FEZ) as a viable option versus other avenues, like Foreign Direct Investment (FDI). This thesis explores FEZ as a tool to fetch investment for the development of Libya's economy. Some of the factors in favour of FEZ are believed to be employment opportunities for local labour, enhancing their skills and knowledge, as well as bringing new technology along with management styles, thereby boosting not only the national economy, but overall growth of society. This thesis examines these arguments by comparing existing FEZ in various parts of the world, particularly Al-Ameria FEZ in Alexandria, Egypt. The case study revolves around this FEZ, as it has geographical and cultural similarity to that of Libya. In stimulating a potential decision making process, cost-benefit analysis is carried out to evaluate financial return against benefits envisaged. Finally, the study recommends the perceived best way forward in establishing successful FEZ to achieve desired sustainable economic growth in Libya. This is the first study of its kind in the Arab world that covers cost-benefit analysis of different industries within FEZ, and could prove to be a guideline for academics and business communities working in this field

    The amino acid transporter SLC7A11 expression in breast cancer

    Get PDF
    Breast cancer (BC) is a complex disease with diverse molecular profiles and clinical outcomes, making it challenging to develop effective treatments. Metabolic reprogramming is a hallmark of cancer and SLC7A11, an amino acid transporter, plays a crucial role in this process. This study investigated the role of SLC7A11 in BC using genomic, transcriptomic, and protein analyses.SLC7A11 gene copy number and mRNA expression were evaluated using the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort (n=1,980) and Breast Cancer Gene Expression Miner (n=4,712). SLC7A11 protein was assessed using immunohistochemistry in a large BC cohort (n=1,981). Additionally, The Cancer Genome Atlas (TCGA) dataset was used to explore SLC7A11 DNA methylation patterns using MethSurv (n=782) and association of SLC7A11 mRNA expression with immune infiltrates using TIMER (n=1,100). High SLC7A11 mRNA and SLC7A11 protein expression were significantly associated with high tumor grade (p≤0.02). Interestingly, SLC7A11 copy number gain was observed in HER2+ tumors (p=0.01) whilst SLC7A11 mRNA expression was higher in basal-like/triple-negative (TN) and luminal B tumors (p≤0.02). In contrast, high SLC7A11 protein expression was predominantly observed in Estrogen Receptor (ER)-negative and TN BC. SLC7A11 correlated with other amino acid transporters and glutamine metabolism enzymes and with neutrophil and macrophage infiltration.These findings suggest that SLC7A11 plays a significant role in BC metabolism and may be a potential therapeutic target. Further studies are needed to elucidate its precise mechanisms and explore its therapeutic potential

    A density functional study of structural and elastic properties of LaN under high pressure

    No full text
    Structural and elastic properties of LaN at normal and high pressures are investigated using ab initio calculations based on full-potential linearized augmented plane wave (FP-LAPW) within both local density approximation (LDA) and generalized gradient approximation (GGA). Our results concerning equilibrium lattice parameter and bulk modulus agree well with the available experimental and previous theoretical findings. The transition pressure from NaCl (B1) to CsCl (B2) phase is found to be 31.05 GPa from LDA, and 42.2 GPa from GGA. To the best of our knowledge, the elastic properties for LaN in the B1 structure in the presence of pressure have never been reported so far. The linear pressure coefficients of elastic constants and their related bulk modulus are determined from the pressure dependence of these parameters. Furthermore, the mechanical stability criteria for LaN in B1 phase are found to be fulfilled at normal conditions

    ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Estrogen Receptor Positive Breast Cancer

    No full text
    Introduction: ATF4, a stress-responsive transcription factor that upregulates adaptive genes, is a potential prognostic marker and modulator of glutamine metabolism in breast cancer. However, its exact role remains to be elucidated.Methods: ATF4 expression was evaluated at genomic and transcriptomic levels using METABRIC (n=1980), GeneMiner (n=4712) and KM-Plotter datasets. Proteomic expression was assessed via immunohistochemistry (n=2225) in the Nottingham Primary Breast Cancer Series. ATF4 genomic copy number (CN) variation and mRNA/protein in association with clinicopathological parameters, amino acid transporters (AATs), and patient outcome was investigated. Results: Genomic, transcriptomic, and proteomic overexpression of ATF4 was associated with more aggressive ER-negative tumours. ATF4 mRNA and protein expression were significantly associated with increased expression of glutamine related AATs including SLC1A5 (p<0.01) and SLC7A11 (p<0.02). High ATF4 and SLC1A5 protein expression was significantly associated with shorter breast cancer-specific survival (p<0.01), especially in ER+ tumours (p<0.01), while high ATF4 and SLC7A11 protein expression was associated with shorter survival (p<0.01).Conclusion: These findings suggest a complex interplay between ATF4 and AATs in breast cancer biology and underscore the potential role for ATF4 as a prognostic marker in ER+ breast cancer, offering a unique opportunity for risk stratification and personalised treatment strategies

    Tripartite Motif Containing 2, a glutamine metabolism-associated protein, predicts poor patient outcome in triple negative breast cancer treated with chemotherapy

    No full text
    Background Breast cancer (BC) remains heterogeneous in terms of prognosis and response to treatment. Metabolic reprogramming is a critical part of oncogenesis and a potential therapeutic target. Glutaminase (GLS), which generates glutamate from glutamine, plays a role in triple negative breast cancer (TNBC). However, targeting GLS directly may be difficult, as it is essential for normal cell function. This study aimed to determine potential targets in BC associated with glutamine metabolism and evaluate their prognostic value in BC.Methods The iNET model (https://inetmodels.com) was used to identify genes in BC that associated with GLS using RNA-sequencing data. The prognostic significance of Tripartite Motif Containing 2 (TRIM2) mRNA was assessed in BC transcriptomic data (n=16,575), and TRIM2 protein expression was evaluated using immunohistochemistry (n=749) in early-stage invasive breast cancer patients with long-term follow-up. The associations between TRIM2 expression and clinicopathological features and patient outcome were evaluated. ResultsPathway analysis identified TRIM2 expression as an important gene co-expressed with high GLS expression in BC. High TRIM2 mRNA and TRIM2 protein expression were associated with TNBC (p<0.01). TRIM2 was a predictor of poor distant metastasis free survival (DMFS) in TNBC (p<0.01) which was independent of established prognostic factors (p<0.05). particularly in those who received chemotherapy (p<0.05). In addition, TRIM2 was a predictor of shorter DMFS in TNBC treated with chemotherapy (p<0.01).Conclusion This study provides evidence for association between TRIM2 and poor patient outcome in TNBC especially those treated with chemotherapy. The molecular mechanisms and functional behaviour of TRIM2 and the functional link with GLS in BC warrant further exploration using in vitro models
    corecore